BioMed Realty Trust Reports Second Quarter 2008 Financi...(/p Cancer Institute Inc. and the Im...),Health

Cancer Institute, Inc., and the Immune Disease Institute, Inc., at the

Center for Life Science | Boston

-- Completed the sale of 6,129,000 shares of common stock at $25.50 per

share, resulting in net proceeds of approximately $149.7 million

-- Purchased the minority interest in the entity that owns our Waples

property in San Diego, increasing our ownership interest to 100% of the

property

-- Added John Bonanno to our development team as Vice President,

Development, who brings more than 18 years of experience in commercial

real estate and life science business to the company

"We continue to execute well in all aspects of our business, generating yet another quarter of strong financial results. Despite a very turbulent macro-economic environment, the demand for life science real estate remains relatively strong, and we are pleased with our sustained progress on the leasing front," commented Alan D. Gold, President and Chief Executive Officer of BioMed Realty Trust.

"In addition, as evidenced by the achievement of construction milestones at our Center for Life Science | Boston, Towne Centre Drive, Landmark at Eastview and 530 Fairview Avenue properties, we are making excellent progress across all of our development projects and expect these properties to constitute significant drivers of our future growth and continued solid financial performance."

Second Quarter 2008 Financial Results

Rental revenues for the quarter were $54.2 million, representing a 9.6% increase versus the second quarter of 2007. Same property net operating income increased 6.1% on a cash basis for the second quarter of 2008 compared to the second quarter of 2007.

Total revenues for the quarter were $70.8 million, compared to $68.4 million in the second quarter of 2007. Net income available to common stockholders for the quarter was $14.1 million, or $0.20 per diluted share, compare
'/>"/>